Impaired Cognitive Functioning in Patients with Tyrosinemia Type I Receiving Nitisinone-Reference-Cited by-同舟云学术

Impaired Cognitive Functioning in Patients with Tyrosinemia Type I Receiving Nitisinone

Published:2014-02 Issue:2 Volume:164 Page:398-401
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Bendadi Fatiha,de Koning Tom J.,Visser Gepke,Prinsen Hubertus C.M.T.,de Sain Monique G.M.,Verhoeven-Duif Nanda,Sinnema Gerben,van Spronsen Francjan J.,van Hasselt Peter M.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference15 articles.

1. Hypertyrosinemia;Mitchell,2001

2. Treatment of hereditary tyrosinemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase;Lindstedt;Lancet,1992

3. Tyrosinemia: a review;Russo;Pediatr Dev Pathol,2001

4. The genetic tyrosinemias;Scott;Am J Med Genet C Semin Med Genet,2006

5. Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatment;van Spronsen;Hepatology,1994

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 12-month, longitudinal, intervention study examining a tablet protein substitute preparation in the management of tyrosinemia;Molecular Genetics and Metabolism Reports;2024-09

2. Decoding hepatorenal tyrosinemia type 1: Unraveling the impact of early detection, NTBC, and the role of liver transplantation;Canadian Liver Journal;2024-02-26

3. Nonheme mono- and dioxygenases;Metalloenzymes;2024

4. Inborn Errors of Carbohydrate, Ammonia, Amino Acid, and Organic Acid Metabolism;Avery's Diseases of the Newborn;2024

5. The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12 cells. Implications for treatment of phenylketonuria, tyrosinemia type 1 and comorbid neurodevelopmental disorders;Neurochemistry International;2023-12